OpenEvidence

Assess

Platforms

An AI-powered medical search and chatbot platform for clinicians.

Why it's here

Placed in Assess: 1 article(s) of evidence from 1 source(s), led by funding news, with 1 in the last 30 days. Confidence 24%. Low accumulated evidence, so it defaults conservatively pending more signal.

Evidence (1)

8Ars Technica AI·10/21/2026funding
OpenEvidence Hits $15 Billion as Doctors Adopt Its AI Search Tool
OpenEvidence, a Miami-based AI search startup founded in 2022, has reached a $15 billion valuation as many U.S. doctors use its chatbot to search medical journals and clinical guidelines. The company says physicians processed more than 42 million prompts last month, highlighting rapid adoption in healthcare and raising questions about the role of AI in patient care.